nitric oxide comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2026-07-28. Where a claim depends on a specific study, the study is described rather than over-claimed.
BPC-157 is a synthetic pentadecapeptide whose sequence is commonly given as Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. It is described in the literature as a fragment of a larger protein found in human gastric juice, referred to as body protection compound. The peptide was first characterized in the early 1990s by a research group in Zagreb, Croatia. Its molecular formula is C62H98N16O22 and its monoisotopic mass is approximately 1419 daltons.
Supplied material is typically a lyophilized white to off-white powder. The peptide is freely soluble in water and in common aqueous buffers, which allows it to be handled as a stock solution. Because the sequence contains no cysteine, disulfide cross-linking is not a route of degradation. The absence of aromatic residues means ultraviolet absorbance at 280 nm is minimal, so quantification usually relies on peptide bond absorbance near 214 nm or on amino acid analysis.
Common synonyms in catalogs include pentadecapeptide BPC 157, BPC157, and the full sequence name. A CAS registry number in the 137525-51-0 range is frequently listed, though the assignment should be verified against the supplier certificate of analysis. The name itself is not a pharmacopoeial designation, and there is no standardized international nonproprietary name. Distinguishing genuine material from related fragments generally requires mass spectrometry, since several truncated sequences share similar chromatographic behavior.
Lyophilized peptide is normally kept at minus twenty degrees Celsius or colder, away from light and moisture. Powder held under those conditions is widely treated as stable for long periods, although published stability studies for this exact sequence are sparse and often come from suppliers rather than independent laboratories. Once dissolved, solutions are generally handled cold and used within a short window, because peptide bonds can hydrolyze over time. Repeated freeze-thaw cycles are usually avoided to limit losses, and exact shelf-life figures depend on the buffer and the concentration involved.
Purity is ordinarily reported as a percentage from reverse-phase high-performance liquid chromatography, where the area of the main peak is compared with the total peak area. Identity is confirmed by mass spectrometry, since the measured mass can be checked against the value calculated from the sequence. Some certificates also include amino acid analysis or sequence confirmation by tandem mass spectrometry. A single purity number does not describe the profile of related impurities, so the underlying chromatogram and spectrum usually carry more information than the headline figure.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white lyophilized powder | Assessed by visual inspection under ordinary laboratory lighting |
| Molecular mass | Approximately 1419 Da | Monoisotopic mass for the fifteen-residue sequence |
| Solubility class | Freely soluble in water | Stock solutions commonly prepared in water or aqueous buffer |
| Typical storage temperature | -20 °C or below, desiccated | Lyophilized powder; repeated freeze-thaw cycles are usually avoided |
| Common analytical method | Reversed-phase HPLC with UV detection | Frequently paired with mass spectrometry to confirm identity |
Human data are far more limited than animal data. A small number of clinical reports exist, generally with few participants and without the randomization or blinding expected in later-phase trials. No large, independently replicated human trial has appeared in the indexed peer-reviewed literature. Statements about effects in people therefore rest on extrapolation from animal work rather than on direct evidence, and the strength of that extrapolation remains an open question rather than a settled matter.
Proposed mechanisms include interaction with the nitric oxide system, modulation of growth factor signaling, and effects on blood vessel formation. None of these has been established as the primary mode of action, and some proposed pathways rest on indirect measurements. Whether the reported effects depend on a specific receptor has not been determined. Stability in gastric acid, unusual for a peptide of this size, is also reported in animal work, but the reason for it is not firmly established.
BPC-157 is a synthetic peptide built from fifteen amino acids, referred to in the literature as a pentadecapeptide. Its sequence was derived from a larger protein found in human gastric juice, commonly called body protection compound. Researchers first described the fragment in the early 1990s and named it after the parent protein plus a numeric identifier. The peptide does not correspond to a single marketed medicine; it is primarily a laboratory research material. Suppliers distribute it as a lyophilized powder intended for experimental use.
Published work on BPC-157 spans several decades and covers a wide range of experimental models. Much of the early literature reports outcomes in animal studies involving induced injury to the gastrointestinal tract, tendons, and other tissues. The volume of preclinical reports is large, while controlled human trials remain scarce. This imbalance is a recurring point of discussion, because animal findings do not automatically translate into human effects. Reviews often note that study designs differ substantially across laboratories.
Interest in the peptide has grown through online communities that discuss self-administered use, which sits outside formal research settings. Regulatory status varies by country, and in many jurisdictions the compound is not approved as a therapeutic product. Questions about optimal routes of administration, long-term effects, and dose-response relationships remain open. Published pharmacokinetic data in humans are limited, and much of what circulates in popular discussion is extrapolated from animal work rather than measured directly in people.
BPC-157 is a synthetic peptide built from fifteen amino acid residues. Its sequence comes from a larger protein fragment that researchers isolated from human gastric juice and described as a body protection compound. The fragment contains glycine, glutamic acid, five prolines, lysine, alanine, two aspartic acids, leucine, and valine. The number 157 in the name refers to the position of the stretch within the parent protein. Material used in laboratories is manufactured rather than extracted from stomach fluid.
The molecule carries 15 residues, a molar mass near 1419.5 g/mol, and the formula C62H98N16O22. Its structure features a proline-rich central region, a pair of adjacent aspartic acid residues, and no cysteine. The absence of cysteine means no disulfide bonds can form, which simplifies refolding and reconstitution. Suppliers usually ship the material as a freeze-dried powder that appears white to off-white. It dissolves readily in water and in saline solutions.
Published storage guidance follows general peptide practice rather than product-specific studies. The dry powder is typically kept at minus 20 degrees Celsius, away from light and moisture. Once reconstituted, solutions are generally refrigerated and used over days to weeks, because the aqueous environment slowly promotes hydrolysis and oxidation. Long-term data on degradation rates or breakdown products are sparse. Stated shelf lives from different producers vary widely, reflecting the absence of a shared reference standard.
This last point is actually fairly intuitive: Leaving an adhesive exposed to air too long gets it dirty, and its adhesive strength will decrease. This is observed in the experiment: when mica is cleaved in air, its cleavage energy, W121 or Wmica/air/mica, is smaller than the cleavage energy in vacuum, Wmica/vac/mica, by a factor of 13.
== Early life == Carlisle was selected by Essendon with pick 24 in the 2009 National Draft. Like fellow draftee Jake Melksham, he is a local to the Essendon area. He played with the Calder Cannons in the TAC Cup and Craigieburn in the EDFL. He represented Vic Metro in the 2009 AFL National Under 18 Championships and was part of the 2009 Premiership team.
== Health hazards == Several chemical substances have been found to be effective in skin whitening, but some have been proven or suspected to be toxic. This includes compounds containing mercury, which can cause neurological and kidney problems. These products also contain collagen, which can be harmful to the skin. It is present in day creams and beauty masks. Collagen is an insoluble fibrous protein that is too large to penetrate the skin, thus it can clog pores. The use of these products can be hazardous to health, potentially causing acne, stretch marks, skin cancer, hypertension, or diabetes, especially when the product contains hydroquinone, mercury, cortisone, or vitamin A. Allergic reactions or undesirable effects, such as uneven hyperpigmentation or patchy depigmentation, can also occur. Among the ingredients, hydroquinone is also commonly found and is responsible for multiple side effects. It can interfere with the reagents used in capillary blood glucose meters, artificially raising blood glucose levels. In 1997, in Paris, the French police dismantled a network involved in the illegal trafficking of skin lightening products, primarily targeting Congolese migrants. Such products represent a significant market despite their health risks. Users resort to preparations containing mercury or bleach, or products containing corticosteroids or quinine. The Saint-Louis Hospital in Paris had to establish a specialized department to deal with the skin disorders caused by skin bleaching.
Sources: en.wikipedia.org
The history of carbohydrates, to some extent, is the history of sugar cane, which was first grown in New Guinea. The mass cultivation occurred in India where techniques were developed for the isolation of crystalline sugar. Cane sugar and its cultivation reached Europe around the 13th Century and then expanded to the New World, where industrialization occurred. The chemistry and biochemistry of carbohydrates can be traced to 1811. On that year Constantin Kirchhoff discovered that grape sugar (glucose) forms when starch is boiled with acid. The starch industry started the following year. Henri Braconnot discovered in 1819 that sugar is formed through the action of sulfuric acid on cellulose. William Prout, after chemical analyses of sugar and starch by Joseph Louis Gay-Lussac and Thénard, gave this group of substances the group name "saccharine." The term "carbohydrate" was first proposed by German chemist Carl Schmidt in 1844. In 1856, glycogen, a form of carbohydrate storage in animal livers, was discovered by French physiologist Claude Bernard. Emil Fischer received the 1902 Nobel Prize in Chemistry for his work on sugars and purines. For the discovery of glucose metabolism, Otto Meyerhof received the 1922 Nobel Prize in Physiology or Medicine.
So it was proposed that succinyl amino acid derivative should be an ACE inhibitor and succinyl-L-proline was found to be such an inhibitor. It was also known that the nature of penultimate amino acid residue of a peptide substrate for ACE influences binding to the enzyme. The acyl group of the carboxyalkanoyl amino acid binds the zinc ion of the enzyme and occupies the same position at the active site of ACE as the penultimate. Therefore, the substituent of the acyl group might also influence binding to the enzyme. A 2-methyl substituent with D configuration was found to enhance the inhibitory potency by about 15 fold of succinyl-L-proline. Then the search for a better zinc-binding group started. Replacement of the succinyl carboxyl group by nitrogen-containing functionalities (amine, amide or guanidine) did not enhance inhibitory activity. However a potency breakthrough was achieved by the replacement of the carboxyl group with a sulfhydryl function (SH), a group with greater affinity for the enzyme bound zinc ion. This yielded a potent inhibitor that was 1000 times more potent than succinyl-L-proline. The optimal acyl chain length for mercaptoalkanoyl derivates of proline was found to be 3-mercaptopropanoyl-L-proline, 5 times greater than that of 2-mercaptoalkanoyl derivates and 50 times greater than that of 4-mercaptoalkanoyl derivates. So the D-3-mercapto-2-methylpropanoyl-L-proline or Captopril was the most potent inhibitor.
== Treatment == While the disease is not reversible, treatments can slow further worsening. This may include the use of corticosteroids or immunosuppressive medication which may have an effect on the ability to receive a lung transplant if offered. If patients have difficulty breathing (hypoxemia) oxygen can be supplemented. Routine vaccinations are recommended for patients with chronic lung disease to prevent complications from secondary infections due to pneumonia and influenza.
== Conservation == Currently this species is not considered endangered or threatened by any agencies, however there are a list of potential threats that may effect their survival. Among these threats include fatal diseases such as Sponge Orange Band (SOB), environmental changes, and cyclical bleaching. Researchers are unsure what the cause of SOB is, but evidence supports the hypothesis that environmental changes, rising water temperature in particular, is responsible for the disease.
Sources: en.wikipedia.org
In the morning of 8 October, Hezbollah fired rockets and shells at the Shebaa Farms region in support of Hamas's attack onto Israel; in response, the Israel Defense Forces (IDF) fired artillery shells and a drone into southern Lebanon. Two Lebanese children were reportedly injured by broken glass. The next day, Israel exchanged a series of airstrikes on southern Lebanon near the towns of Marwahin, Ayta ash Shab and Dhayra in the Bint Jbeil district. This was after numerous Palestinian militants infiltrated the Israeli border, which Hezbollah denied involvement with. The Palestinian Islamic Jihad militia claimed responsibility for the armed infiltration. The IDF killed at least two perpetrators (likely Palestinians), while a third returned to Lebanon. A Hezbollah media source announced three of Hezbollah's members died in the IDF retaliation. Hezbollah fired rockets and artillery in retaliation. During the clashes, two Israeli soldiers and Lt. Col Alim Abdallah, Deputy Commander of the IDF's 300th Brigade, were killed and another three were wounded. On 11 October, Hezbollah fired anti-tank missiles at an IDF position and claimed to have produced casualties. In response, the IDF shelled the area where the attack was launched. The Lebanese-Italian hospital in Tyre admitted three injured civilians. The IDF ordered residents of northern Israel to seek shelter following reports of drones being launched from southern Lebanon. A Patriot missile was launched to intercept a suspicious projectile, after which the IDF found that the object in question was not a drone.
Long-term storage of radioactive waste requires the stabilization of the waste into a form that will neither react nor degrade for extended periods. It is theorized that one way to do this might be through vitrification. Currently at Sellafield, the high-level waste (PUREX first cycle raffinate) is mixed with sugar and then calcined. Calcination involves passing the waste through a heated, rotating tube. The purposes of calcination are to evaporate the water from the waste and de-nitrate the fission products to assist the stability of the glass produced. The 'calcine' generated is fed continuously into an induction heated furnace with fragmented glass. The resulting glass is a new substance in which the waste products are bonded into the glass matrix when it solidifies. As a melt, this product is poured into stainless steel cylindrical containers ("cylinders") in a batch process. When cooled, the fluid solidifies ("vitrifies") into the glass. After being formed, the glass is highly resistant to water. After filling a cylinder, a seal is welded onto the cylinder head. The cylinder is then washed. After being inspected for external contamination, the steel cylinder is stored, usually in an underground repository. In this form, the waste products are expected to be immobilized for thousands of years. The glass inside a cylinder is usually a black glossy substance. All this work (in the United Kingdom) is done using hot cell systems. Sugar is added to control the ruthenium chemistry and to stop the formation of the volatile RuO4 containing radioactive ruthenium isotopes.
Shut-down separator (for overheating) Tear-away tab (for internal pressure relief) Vent (pressure relief in case of severe outgassing) Thermal interrupt (overcurrent/overcharging/environmental exposure) These features are required because the negative electrode produces heat during use, while the positive electrode may produce oxygen. However, these additional devices occupy space inside the cells, add points of failure, and may irreversibly disable the cell when activated. Further, these features increase costs compared to nickel metal hydride batteries, which require only a hydrogen/oxygen recombination device and a back-up pressure valve. Contaminants inside the cells can defeat these safety devices. Also, these features cannot be applied to all kinds of cells; prismatic high-current cells cannot be equipped with a vent or thermal interrupt. High-current cells must not produce excessive heat or oxygen, lest there be a failure, possibly violent. Instead, they must be equipped with internal thermal fuses which act before the anode and cathode reach their thermal limits. Replacing the lithium cobalt oxide positive electrode material with a lithium metal phosphate such as lithium iron phosphate (LFP) improves cycle counts, shelf life and safety, but lowers capacity. As of 2006, these safer lithium-ion batteries were mainly used in electric cars and other large-capacity battery applications, where safety is critical. In 2016, an LFP-based energy storage system was chosen to be installed in Paiyun Lodge on Mt.Jade (Yushan) (the highest lodge in Taiwan).
Sources: en.wikipedia.org
It is a synthetic peptide built from fifteen amino acids, with a mass of roughly 1419 daltons. The sequence is reported to match a fragment of a protein present in human gastric juice. It is not a naturally circulating hormone.
It is normally supplied as a lyophilized powder in a sealed vial. The powder dissolves readily in water, and stock solutions are typically prepared shortly before use. Cold storage is standard laboratory practice.
The letters are generally read as shorthand for body protection compound. That label comes from the original research context rather than from formal nomenclature. No standardized nonproprietary name exists for the peptide.
The standard approach is reverse-phase high-performance liquid chromatography, reported as a percentage of total peak area. Because that figure alone says little about the nature of the impurities, the accompanying chromatogram is normally the more useful document for judging a batch.